glp-1 and dpp4 together Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment GLP-1 analogues and DPP-4 inhibitors

Interpretation requires context: It should be evaluated alongside symptoms, other labs, and diet

48:S181-S206 [PMC free article: PMC11635045] [PubMed: 39651989] 9

Noopept (or N-phenylacetyl-L-prolylglycine ethyl ester), for example, is a strong, branded nootropic that may come with some more risks than others

Gastroenterology (2008) 134:688

Combining it with blood thinners significantly raises the risk of internal bleeding

Insufficient fluid intake with fibre supplements can lead to intestinal obstruction, oesophageal blockage, or worsening constipationrisks that are heightened by the slowed gastric emptying from GLP-1 therapy